In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Blood pressure monitor guidelines

This article was originally published in The Gray Sheet

Executive Summary

Central (or aortic) pulse pressure, which can be measured noninvasively with Omron Healthcare's HEM-9000AI monitor, is added to the list of blood pressure indicators in the new European Society of Hypertension/European Society of Cardiology 1guidelines for managing hypertension. The guidelines, released in June, note that the prognostic role of the Omron approach, which estimates aortic blood pressure based on a reading from a peripheral artery, still "needs to be further confirmed in more large-scale observational and interventional studies" before it drives physician practice. HEM-9000AI has been available in the United States since 2006 and in Japan, where the firm is based, since 2005. Omron plans to launch the device in Europe and other parts of Asia in the near future...

You may also be interested in...

3D Carbon Partners With Resolution Medical To Produce More Than 1 Million Nasal Swabs A Week

Resolution Medical teamed up with Carbon to introduce more than one million 3D-printed nasal swabs to address the shortage for COVID-19 testing.

ACC 2020: Medtronic’s Evolut TAVR Works In Low-Risk Bicuspid Study

Early results from the Low-Risk Bicuspid study of the Evolut transcatheter aortic valve replacement system showed low rates of all-cause mortality or stroke.

COVID-19 Will Spur Decentralized and Hybrid Trials – Novartis Hails Digital Investment

The reality is that many trials requiring hospital based tests and interventions cannot be replaced, but crisis will spur take up where practical.




Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts